Zastaprazan
Zastaprazan (trade name Jaqbo) is a pharmaceutical drug for gastrointestinal disorders.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zastaprazan (trade name Jaqbo) is a pharmaceutical drug for gastrointestinal disorders. It is classified as a potassium-competitive acid blocker. In April 2024, it was approved for use in South Korea for the treatment of erosive gastroesophageal reflux disease (GERD). In addition, it is in Phase III clinical trials for gastric ulcer and peptic ulcer.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372907189 under CC BY-SA 4.0; modifications have been made.